Crystal Phend

Phase I results show 'big improvement' for what is usually progressive hypertrophy, expert says

AI transformation of the way cardiology uses echo 'is absolutely going to happen, expert says

BPROAD trial replicates SPRINT trial findings in diabetes population in China

VANISH2 trial may set new standard of care for ischemic cardiomyopathy patients

The disease follows a predictable trajectory through mild, moderate, and severe symptoms

Two randomized trials compared intraosseous and intravenous routes for the initial access attempt

Study details an intermediate prognosis with newer microvascular inflammation phenotypes

Recommendation updates also address social determinants of health

Negative results overall hid a benefit for some who won the insurance lottery in Oregon

Amyloid-beta and tau are just one part